{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-098865","form_type":"8-K","ticker":"VIR","cik":"0001706431","company_name":"Vir Biotechnology, Inc.","filed_at":"2022-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.924292+00:00","generated_at":"2026-06-26T08:51:53.056655+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Vir Biotechnology appoints Johanna Friedl-Naderer as EVP and COO","bullets":["Appointed Johanna Friedl-Naderer, age 54, as EVP and COO effective April 4, 2022.","She previously served as EVP and Chief Business Officer, Global since March 2022.","Prior to Vir, spent 20+ years at Biogen, most recently as President of Europe, Canada & Partner Markets.","Responsible for business development, finance, product development/regulatory, and corporate affairs.","Compensation has not yet been determined; will be disclosed in a future amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-098865","json":"https://secwatch.observer/filing/0001193125-22-098865.json","markdown":"https://secwatch.observer/filing/0001193125-22-098865.md","text":"https://secwatch.observer/filing/0001193125-22-098865.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1706431/000119312522098865/0001193125-22-098865-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1706431/000119312522098865/d254319d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T08:51:53.056655+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"13ffdb0ff3","claim":"Johanna Friedl-Naderer was appointed as Executive Vice President and Chief Operating Officer at Vir Biotechnology, Inc..","evidence_excerpt":"Effective as of April 4, 2022, the Board of Directors (the “Board”) of Vir Biotechnology, Inc. (the “Company”) appointed Johanna Friedl-Naderer, age 54, to serve as Executive Vice President and Chief Operating Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1706431/000119312522098865/0001193125-22-098865-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}